R
Runway Growth Finance Corp.
RWAYCIK 0001653384NasdaqEmerging GrowthMarylandITFY ends Dec 31
Period
FY 2025
Revenue
—
Net Income
$34.05M
Total Assets
$960.11M
Equity
$484.97M
Shares Out
36.13M
Op. Cash Flow
$186.31M
Business
Runway Growth Finance Corp. is an externally managed, non‑diversified closed‑end management investment company that provides specialty financing to high‑growth companies. It offers senior secured loans, hybrid debt and equity financings, warrants and other equity positions designed to be more flexible than traditional credit and less dilutive than equity. Its primary business segments are Sponsored Growth Lending and Non‑Sponsored Growth Lending, and it also participates in joint ventures and co‑investment arrangements. The company focuses on U.S. late‑ and growth‑stage technology, healthcare, business and financial services companies through direct origination and sponsor relationships.
Summary from filing dated 2025-03-20
Financials
Consolidated Statement of Income
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Other income | 582,000 | 531,000 | 488,000 | 2,000 | 1,000 | |
| Total investment income | 137 | 145 | 164 | 108 | 71 | |
| Management fees | 16 | 16 | 17 | 12 | 9 | |
| Incentive fees | 14 | 15 | 19 | 13 | 9 | |
| Interest and other debt financing expenses | 43 | 44 | 43 | 17 | — | |
| Professional fees | 2 | 2 | 2 | 2 | 2 | |
| Administration agreement expenses | 3 | 2 | 2 | 2 | 2 | |
| Insurance expense | 646,000 | 829,000 | 1 | 1 | 339,000 | |
| Tax expense | 880,000 | 392,000 | 664,000 | — | — | |
| Other expenses | 1 | 976,000 | 867,000 | 851,000 | 683,000 | |
| Total operating expenses | 80 | 81 | 86 | 48 | 27 | |
| Net investment income | 57 | 64 | 78 | 60 | 44 | |
| Net realized gain (loss) on investments | 3 | −3 | −18 | — | — | |
| Net realized gain (loss) on forward contracts and foreign currency transactions | −26,000 | 0 | 0 | — | — | |
| Net realized gain (loss) | 3 | −3 | −18 | — | — | |
| Net change in unrealized gain (loss) on investments | −25 | 13 | −16 | — | — | |
| Net change in unrealized gain (loss) on forward contracts and foreign currency transactions | −711,000 | 0 | 0 | — | — | |
| Net change in unrealized gain (loss) | −26 | 13 | −16 | — | — | |
| Net realized and unrealized gain (loss) | −23 | 10 | −34 | — | — | |
| Net increase (decrease) in net assets resulting from operations | 34 | 74 | 44 | 32 | 46 | |
| Net investment income per common share (basic and diluted) | 1.55 | 1.64 | 1.93 | 1.46 | 1.3 | |
| Net increase (decrease) in net assets resulting from operations per common share, Basic | 0.93 | 1.89 | 1.09 | 0.79 | 1.33 | |
| Net increase (decrease) in net assets resulting from operations per common share, Diluted | 0.93 | 1.89 | 1.09 | 0.79 | 1.33 | |
| Weighted average shares outstanding, Basic | 37 | 39 | 41 | 41 | 34 | |
| Weighted average shares outstanding, Diluted | 37 | 39 | 41 | 41 | 34 |
Consolidated Balance Sheet
As of · In millions, except per-share amounts
| Concept | Trend | FY 2026 2026-02-28 | FY 2025 2025-12-31 | FY 2025 2025-09-30 | FY 2025 2025-06-30 | FY 2025 2025-03-31 |
|---|---|---|---|---|---|---|
| Total investments at fair value | — | 927 | — | — | — | |
| Cash and cash equivalents | — | 18 | — | — | — | |
| Interest and fees receivable | — | 8 | — | — | — | |
| Deferred financing costs | — | 4 | — | — | — | |
| Other assets | — | 3 | — | — | — | |
| Total assets | — | 960 | — | — | — | |
| Credit facility | — | 173 | — | — | — | |
| Deferred financing costs | — | −2 | — | — | — | |
| Total debt, less deferred financing costs | — | 435 | — | — | — | |
| Incentive fees payable | — | 14 | — | — | — | |
| Interest payable | — | 7 | — | — | — | |
| Foreign currency forward contracts | — | 711,000 | — | — | — | |
| Secured borrowings | — | 15 | — | — | — | |
| Accrued expenses and other liabilities | — | 3 | — | — | — | |
| Total liabilities | — | 475 | — | — | — | |
| Commitments, Contingencies, and Off-Balance Sheet Arrangements (Note 8) | — | — | — | — | — | |
| Common stock, par value | — | 361,000 | — | — | — | |
| Additional paid-in capital | — | 535 | — | — | — | |
| Accumulated undistributed (overdistributed) earnings | — | −50 | — | — | — | |
| Total net assets | — | 485 | — | — | — | |
| Shares of common stock outstanding ($0.01 par value, 100,000,000 shares authorized) | — | 36 | — | — | — | |
| Net asset value per share | 13.42 | 13.42 | 13.55 | 13.66 | 13.48 |
Consolidated Statement of Cash Flows
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Payment-in-kind interest | −16 | −12 | −20 | −9 | −3 | |
| Sales or repayments of investments | 299 | 231 | 296 | 169 | 304 | |
| Payments for derivative contracts | −1 | — | — | — | — | |
| Proceeds from derivative contracts | 1 | — | — | — | — | |
| Net realized (gain) loss on investments | −3 | 3 | 18 | — | — | |
| Net change in unrealized (gain) loss on investments | 25 | −13 | 16 | — | — | |
| Amortization of fixed income premiums or accretion of discounts and end-of-term payments | −5 | −7 | −9 | −7 | — | |
| Amortization of deferred financing costs | 3 | 3 | 3 | 1 | 472,000 | |
| (Increase) decrease in interest and fees receivable | 547,000 | 128,000 | 497,000 | −6 | −301,000 | |
| (Increase) decrease in other assets | −2 | 282,000 | 25,000 | 227,000 | −599,000 | |
| Increase (decrease) in incentive fees payable | 338,000 | 2 | 4 | 3 | 1 | |
| Increase (decrease) in interest payable | −987,000 | 979,000 | 543,000 | 6 | −219,000 | |
| Increase (decrease) in accrued expenses and other liabilities | 1 | −435,000 | 1 | 92,000 | 486,000 | |
| Net cash provided by (used in) operating activities | 186 | 70 | 112 | −360 | −61 | |
| Payments of deferred financing costs | −4 | −166,000 | −2 | −10 | −400,000 | |
| Borrowings under credit facility | 206 | 211 | 210 | 484 | 161 | |
| Repayments under credit facility | −344 | −172 | −275 | −208 | −199 | |
| Proceeds from secured borrowings | 15 | — | — | — | — | |
| Acquisition/ Repurchase of stock | −13 | −36 | — | −11 | — | |
| Retirement of shares | — | −1,000 | — | — | — | |
| Dividends paid to stockholders | −51 | −70 | −73 | −52 | −18 | |
| Net cash (used in) provided by financing activities | −174 | −67 | −115 | 361 | 51 | |
| Effect of foreign currency exchange rates | 6,000 | — | — | — | — | |
| Net increase (decrease) in cash and cash equivalents | 12 | 3 | −3 | 1 | −10 | |
| Taxes paid | 390,000 | 616,000 | 340,000 | 1,000 | — | |
| Interest paid | 38 | 37 | 38 | 8 | 3 |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro